EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.
| Website | https://eyebiotech.com/ |
| Employees | 109 (86 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Ophthalmology, Vision Restoration, Vision Improvement, Biotechnology, Vision Protection, Advanced Therapies, Eye Health, Retinal Diseases, Innovative Treatments, Ocular Health, Therapeutic Solutions, Ocular Therapeutics, Drug Discovery, Eye Care, Biopharma |
| Competitors | Novartis, AbbVie, Genentech, Amgen, Regeneron, Alcon, Bausch + Lomb, Ocugen, Akcea Therapeutics, EyeGate Pharma (Nasdaq:EYEG) +29 more (view full list) |
Looking for a particular EyeBio employee's phone or email?
EyeBio Questions
Sarah Milsom is the COO of EyeBio.
86 people are employed at EyeBio.
EyeBio is based in London, England.
Top EyeBio Employees
-
Sarah Milsom
Chief Operating Officer at EyeBio
United States22 -
11
-
Keith Baker
Senior Vice President Clinical Development at EyeBio
Chattanooga, TN, US22 -
Yordak Salermo
Vice President Clinical Operations at EyeBio
New York, NY, US35 -
Charles Miller
Associate Vice President at EyeBio
New York, NY, US3 -
Ng Eric
SVP, Biology at EyeBio
Boston, MA, US1 -
Divya Manek
Director, Clinical Operations (Ex US) at EyeBio
London, England, GB1 -
Dave Parker
Sr. Director, Clinical Operations at EyeBio
West Chester, PA, US35 -
David Millband
Executive Director CMC at EyeBio
United Kingdom21
Related Companies
G2Crowd Trusted
300K+
Plugin Users
